All CIRS research papers

7,510 papers, newest first · page 80 of 126

  1. Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study

    Arch Gen Psychiatry · 2005

  2. Detection of the myo‐inositol 4.06‐ppm resonance by selective J rewinding: Application to human prefrontal cortex in vivo

    Magnetic Resonance in Medicine · 2005

  3. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study

    Chinese medical journal · 2005

  4. In vivo effect of chronic hypoxia on the neurochemical profile of the developing rat hippocampus

    Developmental Brain Research · 2005

  5. Evidence of biochemical and biomagnetic interactions in Alzheimer’s disease: an MEG and MR spectroscopy study

    Dementia and Geriatric Cognitive Disorders · 2005

  6. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia

    Journal of Neurology Neurosurgery & Psychiatry · 2005

  7. Decreased prefrontal myo-inositol in major depressive disorder

    Biological Psychiatry · 2005

  8. Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801

    Journal of Neurochemistry · 2005

  9. Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy

    Journal of Neurology · 2005

  10. Quantitative 1HMRS and MRI Volumetry Indicate Neuronal Damage in the Hippocampus of Children with Focal Epilepsy and Infrequent Seizures

    Epilepsia · 2005

  11. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis

    Archives of Neurology · 2005

  12. Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine in a primate model

    American Journal of Neuroradiology · 2005

  13. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T

    American Journal of Neuroradiology · 2005

  14. Jack CR. 1H MR spectroscopy in common dementias

    Natl Med J India · 2005

  15. The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortexin vivo

    Proceedings of the National Academy of Sciences · 2005

  16. High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease

    Journal of Biological Chemistry · 2005

  17. Group I and II metabotropic glutamate receptors alter brain cortical metabolic and glutamate/glutamine cycle activity: a 13C NMR spectroscopy and metabolomic study

    Journal of Neurochemistry · 2005

  18. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study

    Schizophrenia Research · 2005

  19. Contribution of extracellular glutamine as an anaplerotic substrate to neuronal metabolism: a re-evaluation by multinuclear NMR spectroscopy in primary cultured neurons

    Neurochemical Research · 2005

  20. Brain magnetic resonance spectroscopy in Tourette’s disorder

    Journal of the American Academy of Child & Adolescent Psychiatry · 2005

  21. Leptin, immune responses and autoimmune disease. Perspectives on the use of leptin antagonists

    Current Pharmaceutical Design · 2005

  22. Antiinflammatory action of glucocorticoids- new mechanisms for old drugs

    New England Journal of Medicine · 2005

  23. Gene Expression Profiling Reveals Multiple Protective Influences of the Peptide α-Melanocyte-Stimulating Hormone in Experimental Heart Transplantation

    The Journal of Immunology · 2005

  24. Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-stimulating hormone

    Neurotoxicity Research · 2005

  25. Detection of Functionally Active Melanocortin Receptors and Evidence for an Immunoregulatory Activity of α-Melanocyte-Stimulating Hormone in Human Dermal Papilla Cells

    Endocrinology · 2005

  26. α-Melanocyte-Stimulating Hormone Suppresses Antigen-Induced Lymphocyte Proliferation in Humans Independently of Melanocortin 1 Receptor Gene Status

    The Journal of Immunology · 2005

  27. Effect of Alpha-Melanocyte-Stimulating Hormone on Interleukin 8 and Monocyte Chemotactic Protein 1 Expression in a Human Retinal Pigment Epithelial Cell Line

    Ophthalmic Research · 2005

  28. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on IL-6, IL-8, and MCP-1 expression in human retinal pigment epithelial cell line

    Current Eye Research · 2005

  29. The nervous system and innate immunity: the neuropeptide connection

    Nature Immunology · 2005

  30. Antiendotoxin properties of cationic host defence peptides and proteins

    Journal of Endotoxin Research · 2005

  31. Lipopolysaccharide-induced leptin synthesis and release are differentially controlled by alpha-melanocyte-stimulating hormone

    NeuroImmunoModulation · 2005

  32. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (α-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages

    Journal of Neuroimmunology · 2005

  33. Transcription Factor NF‐κB: A Sensor for Smoke and Stress Signals

    Annals of the New York Academy of Sciences · 2005

  34. Multiple Chemical Sensitivity Syndrome (MCS) – suggestions for an extension of the US MCS-case definition

    International Journal of Hygiene and Environmental Health · 2005

  35. Changes in Levels of Nerve Growth Factor in Nasal Secretions after Capsaicin Inhalation in Patients with Airway Symptoms from Scents and Chemicals

    Environmental Health Perspectives · 2005

  36. National prevalence of asthma and chemical hypersensitivity: an examination of potential overlap

    Journal of Occupational and Environmental Medicine · 2005

  37. Symptom profile of multiple chemical sensitivity in actual life

    Psychosomatic Medicine · 2005

  38. Evidence for overlap between idiopathic environmental intolerance and somatoform disorders

    Psychosomatic Medicine · 2005

  39. Inflammatory processes in muscle injury and repair

    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2005

  40. Hypersensitivity pneumonitis associated with environmental mycobacteria

    Environmental Health Perspectives · 2005

  41. Mycotoxins as harmful indoor air contaminants

    Applied Microbiology and Biotechnology · 2005

  42. Bacterial strains from moldy buildings are highly potent inducers of inflammatory and cytotoxic effects

    Indoor Air · 2005

  43. Ribotoxic Stress Response to the Trichothecene Deoxynivalenol in the Macrophage Involves the Src Family Kinase Hck

    Toxicological Sciences · 2005

  44. Advances in the molecular diagnosis of ochratoxin A-producing fungi

    Food Additives & Contaminants · 2005

  45. Change in use of gadolinium- enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration Warnings: A cross-sectional study of Veterans Affairs Health Care System Data from 2005-2008

    Yearbook of Diagnostic Radiology · 2005

  46. Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by Candida albicans Blastoconidia and Hyphae

    Infection and Immunity · 2005

  47. Chronic biotoxin-associated illness: Multiple-system symptoms, a vision deficit, and effective treatment

    Neurotoxicology and Teratology · 2005

  48. From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias

    Antimicrobial Agents and Chemotherapy · 2005

  49. A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings

    Neurotoxicology and Teratology · 2005

  50. Off licence and off label prescribing in children: litigation fears for physicians

    Archives of Disease in Childhood · 2005

  51. Off label and unlicensed drugs use in paediatric cardiology

    European Journal of Clinical Pharmacology · 2005

  52. The use of unlicensed and off-label medicines in the neonate

    Seminars in Fetal and Neonatal Medicine · 2005

  53. Latest therapies for biopolar disorder. Looking beyond lithium

    Postgrad Med · 2005

  54. Medications as adjunct therapy for weight loss: approved and off- label agents in use. J Am Diet Assoc 2005: 105(6): 948-959

    2005

  55. Off-label prescribing to children: attitudes and experience of general practitioners

    British Journal of Clinical Pharmacology · 2005

  56. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment

    Journal of the American Academy of Dermatology · 2005

  57. Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with the degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone in the mammalian spinal cord

    Journal of Neuroscience · 2005

  58. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura

    International Journal of Hematology · 2005

  59. Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections

    European Journal of Clinical Microbiology & Infectious Diseases · 2005

  60. Dynamics of muscle microcirculatory oxygen exchange

    Medicine & Science in Sports & Exercise · 2005